Form 8-K - Current report:
SEC Accession No. 0001628280-25-001438
Filing Date
2025-01-14
Accepted
2025-01-14 08:09:06
Documents
14
Period of Report
2025-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aawh-20250113.htm   iXBRL 8-K 30053
2 EX-4.1 ex41firstsupplementalinden.htm EX-4.1 34479
  Complete submission text file 0001628280-25-001438.txt   190776

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aawh-20250113.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aawh-20250113_lab.xml EX-101.LAB 20974
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aawh-20250113_pre.xml EX-101.PRE 12043
16 EXTRACTED XBRL INSTANCE DOCUMENT aawh-20250113_htm.xml XML 2641
Mailing Address 44 WHIPPANY ROAD, SUITE 101 MORRISTOWN NJ 07960
Business Address 44 WHIPPANY ROAD, SUITE 101 MORRISTOWN NJ 07960 (646) 661-7600
Ascend Wellness Holdings, Inc. (Filer) CIK: 0001756390 (see all company filings)

EIN.: 830602006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-254800 | Film No.: 25527806
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)